To cite this paper use one of the standards below:
Antitrypanosomal treatment is scarce and unsatisfactory to fight Chagas’ disease. LINS03 compounds have been developed to find novel and safer alternatives against Trypanosoma cruzi. The amide analogue LINS03018 showed high potency and good selectivity towards amastigotes, although its excessive lipophilicity compromises water solubility, cytotoxicity and drug-likeness.1 Molecular modifications on the aromatic ring and side chain of the amide group were performed to improve water solubility along with lipophilicity. Modifications in the aromatic ring and insertion of vinylic spacer between the aromatic and amide groups resulted in improved physicochemical properties and reduced cytotoxicity. However, most compounds lacked activity towards the parasite. Insertion of the piperazine moiety in the side chain was the most promising modification, yielding compounds active against both forms of T. cruzi, with improved selectivity and physicochemical properties. Metric analysis from lipophilic ligand efficiency (LLE) and drug-likeness indexes denotes the progresses made from LINS03018.2
Con casi 200.000 artículos publicados, Galoá permite a los académicos compartir y descubrir investigaciones de vanguardia a través de nuestra plataforma de publicación académica optimizada y accesible.
Obtenga más información sobre nuestros productos:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Atención: este no es un DOI para el trabajo y, como tal, no se puede usar en Lattes para identificar un trabajo en particular.
Check the link "How to cite" en la página del papel, para ver cómo citar correctamente el papel